A miniaturized, biomimetic model of the human intestine has successfully reproduced long-term enterovirus A71 (EV-A71) ...

Thanks to GLP-1 medicines, losing weight is the easy part. The harder part for many may be convincing their brain that their ...

A major international study led by researchers at the Kennedy Institute of Rheumatology at the University of Oxford has found ...

Losing weight may involve rewiring the gut and the brain at the same time. In a study of obese adults, an intermittent ...

Sleep breathing disorders (SBDs)—including obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation syndromes—represent a major yet under-recognised contributor to global ...

Emerging evidence suggests that leptin, dysbiosis, and altered innate immunity may contribute to poor asthma control in ...

New research suggests obesity may leave a long-lasting “memory” on the immune system, even years after weight loss.

Wegovy showed an average 22.6% weight loss for premenopausal women with obesity, with more than 4 in 10 (41.4%) achieving 25% or more weight loss1.Substantial weight loss was consistent across all men ...

Key action items to advance the field of obesity medications, developed at the Duke Clinical Research Institute's "Anti-Obesity Pharmacotherapy: An Urgent Need for Guidance, Access, and Equity" think ...

Credit: Getty Images New meta-analysis data suggest that temporary intragastric devices significantly improve liver morphology and biochemical markers of hepatocellular injury. Metabolic ...

ABSTRACT: Background: Globally, obesity has become an epidemic. It has been implicated in chronic non-communicable diseases such as diabetes. The risk of diabetes among the obese population has been ...

In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...